Buspirone Safety During Pregnancy
Buspirone can be used during pregnancy when clearly needed, as animal studies show no fetal harm and the only prospective human data available found no major malformations, though adequate controlled human studies are lacking. 1
FDA Classification and Animal Data
Buspirone is FDA Pregnancy Category B, meaning:
- Animal reproduction studies in rats and rabbits at approximately 30 times the maximum human dose showed no fertility impairment or fetal damage 1
- However, adequate and well-controlled studies in pregnant humans have not been performed
- The drug should only be used during pregnancy if clearly needed, as animal studies don't always predict human response 1
Human Pregnancy Data
The most recent and highest quality human evidence comes from a 2022 prospective registry study that provides reassuring preliminary data:
- 68 evaluable women with first-trimester buspirone exposure were followed
- Zero major malformations were observed among 72 infants (including 4 sets of twins) 2
- This represents the only prospectively ascertained sample of pregnancy outcomes after first-trimester buspirone exposure
- The rigorous prospective methodology strengthens these findings 2
Clinical Decision-Making Algorithm
When considering buspirone in pregnancy:
Assess necessity: Is treatment clearly needed for maternal anxiety that impacts quality of life or functioning?
Consider alternatives: Have other non-pharmacologic or better-studied pharmacologic options been exhausted?
If buspirone is indicated:
- The available evidence suggests relative safety
- No teratogenic signal in animals at high doses
- No malformations in the only prospective human cohort
- Benefits of treating maternal anxiety may outweigh theoretical risks
Important Caveats
- The human data sample is small (N=68), so rare malformations cannot be ruled out 2
- No data on labor and delivery effects in humans (though rat studies showed no adverse effects) 1
- Animal studies showing developmental effects used doses far exceeding human therapeutic levels 3
- Studies examining buspirone's protective effects against prenatal stress in animals 4 suggest potential benefits but cannot be extrapolated to clinical practice
Practical Considerations
- Buspirone should be taken consistently either with or without food throughout pregnancy 1
- The medication does not cross-react with benzodiazepines, so it won't prevent withdrawal in patients transitioning from benzodiazepines 1
- Avoid abrupt discontinuation if a patient becomes pregnant while on buspirone; discuss risks/benefits before making changes
The evidence supports that buspirone can be continued or initiated during pregnancy when maternal anxiety requires treatment and the benefits justify use, particularly given the absence of malformations in prospective human data and reassuring animal studies.